AI and NVIDIA BioNeMo Framework aim to revolutionize medical treatments by accelerating drug discovery timelines.NVIDIA BioNeMo offers models tailored for medical research, aiding in the identification and optimization of potential drug candidates.The framework enables analysis of DNA, RNA, proteins, and chemicals for predicting molecular interactions and designing therapeutics at scale.BioNeMo, combined with Google Kubernetes Engine (GKE), facilitates faster iteration, fault tolerance, and orchestration of distributed workloads.BioNeMo includes the BioNeMo Framework for training biomolecular AI models and BioNeMo Blueprints for drug discovery workflows.The integration of BioNeMo with GKE allows for distributed pretraining, model finetuning, and efficient resource utilization.BioNeMo Blueprints offer reference workflows for tasks like protein binder design and molecular docking using advanced AI models.Deployment steps for pretraining ESM-2 model on GKE involve creating a cluster, adding node pools with NVIDIA GPUs, and running pretraining jobs.Steps for deploying BioNeMo Blueprints for inferencing include creating NIM deployments and using port forwarding to interact with pods.GKE's scalability and container orchestration, coupled with BioNeMo's capabilities, streamline AI deployment in life sciences and beyond.